Alum Binding Proteins
Exclusively Licensed
Invention type: Technology, Tangible Property
/
Case number: #21571H
The present disclosure provides immunomodulatory fusion proteins-metal hydroxide complexes comprising an immunomodulatory domain adsorbed to a metal hydroxide via ligand exchange. The disclosure also features compositions and methods of using the same, for example, to treat cancer.
Researchers
Darrell J Irvine
/
Yash Agarwal
/
Tyson Moyer
/
Karl Dane Wittrup
Departments: Department of Chemical Engineering
Technology Areas: Chemicals & Materials: Metals, Nanotechnology & Nanomaterials / Therapeutics: Cell Based Therapy, Proteins & Antibodies
Impact Areas: Healthy Living
-
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
United States of America | Granted | 12,433,946 -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
United States of America | Granted | 11,642,409 -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
Japan | Published application -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
United States of America | Pending -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
Japan | Published application -
immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
European Patent Convention | Published application
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.